More articles from In vitro and In vivo Oncology

You have access
An optimizer for patient-specific therapy with radiopharmaceutical cocktails
Sumudu Katugampola, Jianchao Wang and Roger Howell

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4051;
You have access
Preclinical evaluation of 67Cu-PSMA-617 theranostic as an alternative to 177Lu-PSMA-617 for prostate cancer
Anand Nambisan, Musharraf Khan, Hanan Babeker, Jessica Pougoue Ketchemen, Anjong Tikum, Sharayu Karkare, Fabrice Ngoh Njotu and Humphrey Fonge

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4024;
You have access
In Vitro Evaluation of PSMA Expression Levels Following External Beam Irradiation – Is There Any Potential to Modulate the Efficacy of PSMA-Targeting Prostate Cancer Therapy?
Daria Arbuznikova, Melanie Boll, Anca-Ligia Grosu, Philipp Meyer, Matthias Eder, Constantinos Zamboglou and Ann-Christin Eder

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4033;
You have access
PET imaging and Radiotherapy of Anti-Fibroblast activation protein antibody
Mengxin Xu, Junyi Chen, Pu Zhang and Zhibo Liu

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4060;
You have access
Radiolabeling of anti-CD20 ofatumumab with actinium-225 (225Ac) and therapeutic efficacy in a preclinical disseminated lymphoma model
Mark Longtine, Kyuhwan Shim, Diane Abou, Mark Hoegger, Daniel Thorek and Richard Wahl

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4031;
You have access
Noninvasive evaluation of EGFR expression of digestive tumors using the 99mTc-MAG3-Cet-F(ab')2 based SPECT/CT imaging
Dai Shi, Yuan Cheng, Guobing Liu, Dengfeng Cheng and Hongcheng Shi

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4020;
You have access
Theranostic gemcitabine-loaded collagenase conjugated liposome (GCL)
Jee-eun Hwang, Miyeon Jeon, Wooseung Lee, Jeong-Seob Lee and Hyung-Jun Im

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4054;
You have access
PSMA- versus FAP-RLT: Comparison of efficacy and post-treatment target expression in a double-positive mouse model of prostate cancer
Marco Taddio, Firas Hikmat, Zuo Chunlai, Tamara Lotan, Colm Morissey, Giuseppe Carlucci, Huihui Ye, Caius Radu, Katharina Lueckerath, Johannes Czernin and Christine Mona

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4055;
You have access
Leveraging PSMA-targeted radioligand therapy induced vulnerabilities by STING activation in prostate cancer
Christine Mona, Marco Taddio, Khalid Rashid, Evan Abt, Ethan Rosser, Thuc Le, Katharina Lueckerath, Caius Radu and Johannes Czernin

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4040;
You have access
Attempts to improve the pharmacokinetic Profile of Pharmacophore-modified 99mTc-N4-conjugated GRPR-targeted Compounds via Addition of a Ga-DOTA moiety
Thomas Guenther, Sebastian Fischer, Angela Casini, Constantin Lapa and Wester Hans-Juergen

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4057;

Main menu

User menu

Search

More articles from In vitro and In vivo Oncology

Pages